Publications
45 publications
Funding
12 grants
Active
1 grant- MPIR01CA248747-04Pre-malignant mutation landscape and risk factors for progression to hematologic cancersNational Cancer Institute · 2021–2027
Completed grants (11)
- Co-IHHSN261201500039I HHSN26100005TORFP 2018-E12: Frameshift Peptide Vaccine for the Prevention of Lynch Syndrome-associated Gastrointestinal CancerNational Cancer Institute · 2018–2023
- Co-IR01CA222358-01A1Genetic and Dietary Interactions in MMR Deficient Colon TumorigenesisNational Cancer Institute · 2018–2023 · via Yeshiva University
- MPI80NSSC20K1841The impact of human spaceflight on clonal hematopoiesisNational Aeronautics and Space Administration · 2020–2021
- KPR01CA177165-05Microtubule-Regulated RNA Translation: Implications for Taxane ChemotherapyNational Cancer Institute · 2014–2020
- Co-IDS 192276-01Integrative Single-cell Analysis of Hematological MalignanciesDaiichi Sankyo Co., Ltd. · 2018–2020Contract
- Sub-PIR01HL127499-03Reciprocal Cell-Matrix Interactions During Cell Probing of 3D MicroenvironmentsNational Heart, Lung, and Blood Institute · 2015–2020 · via Vanderbilt University· 2 renewals
- Co-IR01CA102031-10Pharmacological Modulation of Epigenetic Changes in AMLNational Cancer Institute · 2013–2018 · via Beckman Research Institute of the City of Hope· 2 renewals
- KPAbbvie RAADelineating Clinical Response with Single-Cell OmicsAbbVie Inc. · 2016–2017Contract
- KPDP2OD007399-05Identification of Novel Therapies to Ablate Chemoresistant Myeloid Leukemia Stem Cells during RemissionOffice of the Director, NIH · 2010–2015
- Sub-PIR01CA138249-04Gene Networks Essential to Colon Cancer PhenotypeNational Cancer Institute · 2009–2012 · via University of Rochester
External relationships
Other
Twist Bioscience